Societe Generale Reiterates “Buy” Rating for Shire (SHP)
Shire (LON:SHP)‘s stock had its “buy” rating reaffirmed by equities research analysts at Societe Generale in a research note issued to investors on Friday, AnalystRatingsNetwork.com reports. They currently have a GBX 3,615 ($59.57) price target on the stock. Societe Generale’s price objective would suggest a potential upside of 21.11% from the stock’s previous close.
A number of other firms have also recently commented on SHP. Analysts at Panmure Gordon reiterated a “buy” rating on shares of Shire in a research note to investors on Friday. They now have a GBX 3,100 ($51.09) price target on the stock. Separately, analysts at Investec cut their price target on shares of Shire from GBX 38 ($0.63) to GBX 36 ($0.59) in a research note to investors on Thursday. They now have a “buy” rating on the stock. Finally, analysts at Berenberg Bank raised their price target on shares of Shire from GBX 2,350 ($38.73) to GBX 2,900 ($47.79) in a research note to investors on Thursday. They now have a “hold” rating on the stock. One analyst has rated the stock with a sell rating, nine have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of GBX 2,560.63 ($42.20).
Shares of Shire (LON:SHP) traded up 1.14% during mid-day trading on Friday, hitting GBX 3019.00. 1,377,134 shares of the company’s stock traded hands. Shire has a one year low of GBX 1853.0001 and a one year high of GBX 3034.00. The stock’s 50-day moving average is GBX 2816.64 and its 200-day moving average is GBX 2569.43. The company’s market cap is £16.556 billion.
Shire plc (LON:SHP) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.